GDRX - GoodRx Holdings, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
Santa Monica,
United States
Type: Equity
GDRX price evolution
GDRX
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $423.78 | $524.9 | $533.29 | $672.3 |
| Short term investments | ||||
| Net receivables | $159.62 | $161.77 | $144.77 | $143.61 |
| Inventory | ||||
| Total current assets | $626.8 | $750.55 | $732.8 | $872.79 |
| Long term investments | ||||
| Property, plant & equipment | $42.47 | $44.39 | $46.27 | $45.86 |
| Goodwill & intangible assets | $578.57 | $572.87 | $567.11 | |
| Total noncurrent assets | $724.84 | $721.16 | $716.01 | |
| Total investments | ||||
| Total assets | $1354.85 | $1475.39 | $1453.96 | $1588.8 |
| Current liabilities | ||||
| Accounts payable | $12.39 | $16.88 | $33.52 | $36.27 |
| Deferred revenue | ||||
| Short long term debt | $12.42 | $12.16 | $14.96 | |
| Total current liabilities | $114.36 | $102.47 | $116.52 | $122.56 |
| Long term debt | $487.59 | $694.96 | $698.02 | $696.11 |
| Total noncurrent liabilities | $703.52 | $706.37 | $704.28 | |
| Total debt | $707.38 | $710.18 | $711.07 | |
| Total liabilities | $658.41 | $805.99 | $822.89 | $826.84 |
| Shareholders' equity | ||||
| Retained earnings | -$1447.75 | -$1451.72 | -$1458.41 | -$1457.4 |
| Other shareholder equity | ||||
| Total shareholder equity | $669.4 | $631.07 | $761.96 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $672.3 | $757.16 | $941.11 | $971.59 |
| Short term investments | ||||
| Net receivables | $143.61 | $121.67 | $118.08 | $68.73 |
| Inventory | ||||
| Total current assets | $872.79 | $919.69 | $1088.83 | $1086.37 |
| Long term investments | ||||
| Property, plant & equipment | $45.86 | $55.73 | $49.32 | $50.77 |
| Goodwill & intangible assets | $567.11 | $602.05 | $463.47 | $317.83 |
| Total noncurrent assets | $716.01 | $684.95 | $518.8 | $383.75 |
| Total investments | ||||
| Total assets | $1588.8 | $1604.63 | $1607.63 | $1470.11 |
| Current liabilities | ||||
| Accounts payable | $36.27 | $17.7 | $17.5 | $10.29 |
| Deferred revenue | ||||
| Short long term debt | $14.96 | $11.1 | $12.88 | $11.57 |
| Total current liabilities | $122.56 | $76.32 | $81.11 | $59.55 |
| Long term debt | $696.11 | $651.8 | $689.45 | $693.36 |
| Total noncurrent liabilities | $704.28 | $713.48 | $694.83 | $699.2 |
| Total debt | $711.07 | $717.02 | $702.33 | $704.92 |
| Total liabilities | $826.84 | $789.8 | $775.95 | $758.75 |
| Shareholders' equity | ||||
| Retained earnings | -$1457.4 | -$1448.54 | -$1415.71 | -$1390.45 |
| Other shareholder equity | ||||
| Total shareholder equity | $761.96 | $814.83 | $831.68 | $711.36 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $195.25 | $200.61 | $197.88 | $196.64 |
| Cost of revenue | $11.87 | $12.47 | $15.17 | |
| Gross Profit | $183.57 | $188.74 | $185.41 | $181.47 |
| Operating activities | ||||
| Research & development | $30.85 | $31.02 | $32.03 | |
| Selling, general & administrative | $121.04 | $131.07 | $124.12 | |
| Total operating expenses | $163.16 | $168.86 | $178.03 | $199.76 |
| Operating income | $19.88 | $7.38 | -$18.29 | |
| Income from continuing operations | ||||
| EBIT | $26.21 | $14.94 | -$9.81 | |
| Income tax expense | $4.15 | $4.95 | $1.3 | $1.23 |
| Interest expense | -$7.56 | $14.57 | $14.64 | $14.82 |
| Net income | ||||
| Net income | $3.96 | $6.69 | -$1.01 | -$25.87 |
| Income (for common shares) | $6.69 | -$1.01 | -$25.87 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $750.26 | $766.55 | $745.42 | $550.7 |
| Cost of revenue | $66.92 | $65.08 | $46.72 | $29.59 |
| Gross Profit | $683.34 | $701.48 | $698.71 | $521.11 |
| Operating activities | ||||
| Research & development | $135.84 | $143.14 | $125.86 | $61.82 |
| Selling, general & administrative | $466.84 | $502.42 | $524.9 | $716.59 |
| Total operating expenses | $710.35 | $699.74 | $685.3 | $796.83 |
| Operating income | -$27.01 | $1.74 | $13.41 | -$275.72 |
| Income from continuing operations | ||||
| EBIT | $1.16 | $11.01 | $13.46 | -$275.54 |
| Income tax expense | -$46.7 | $9.6 | $15.08 | -$9.83 |
| Interest expense | $56.73 | $34.24 | $23.64 | $27.91 |
| Net income | ||||
| Net income | -$8.87 | -$32.83 | -$25.25 | -$293.62 |
| Income (for common shares) | -$8.87 | -$32.83 | -$25.25 | -$293.62 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $6.69 | -$1.01 | -$25.87 | |
| Operating activities | ||||
| Depreciation | $18 | $16.84 | $44.69 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $26.59 | $25.1 | $28.78 | |
| Total cash flows from operations | $9.7 | $42.59 | $15.87 | |
| Investing activities | ||||
| Capital expenditures | -$17.23 | -$20.61 | -$12.87 | |
| Investments | ||||
| Total cash flows from investing | -$53.7 | -$17.23 | -$20.61 | -$12.87 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $10.04 | -$150.64 | -$75.53 | |
| Net borrowings | -$1.76 | -$3.52 | $0 | |
| Total cash flows from financing | -$333.96 | -$0.86 | -$160.97 | -$125.61 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$248.52 | -$8.39 | -$139 | -$122.61 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$8.87 | -$32.83 | -$25.25 | -$293.62 |
| Operating activities | ||||
| Depreciation | $111.77 | $57.53 | $37.64 | $22.91 |
| Business acquisitions & disposals | -$155.28 | -$144.28 | -$55.79 | |
| Stock-based compensation | $104.82 | $120.23 | $160.46 | $397.29 |
| Total cash flows from operations | $138.29 | $146.78 | $178.78 | $131.34 |
| Investing activities | ||||
| Capital expenditures | -$55.77 | -$55.21 | -$34.46 | -$35.82 |
| Investments | ||||
| Total cash flows from investing | -$55.77 | -$210.5 | -$178.73 | -$91.62 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$96.64 | -$92.56 | $35.02 | $997.8 |
| Net borrowings | -$5.27 | -$7.03 | -$7.03 | -$8.34 |
| Total cash flows from financing | -$167.4 | -$120.23 | -$30.53 | $905.82 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$84.87 | -$183.94 | -$30.48 | $945.54 |
News
Fundamentals
| Market cap | $1.50B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 380.80M |
| Revenue | $790.38M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$16.22M |
| Revenue Q/Q | 8.50% |
| Revenue Y/Y | 7.14% |
| P/E ratio | -92.74 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.90 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 1.11 |
| EPS | -$0.04 |
|---|---|
| ROA | -1.10% |
| ROE | N/A |
| Debt/Equity | 1.09 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 5.48 |
| Quick ratio | N/A |